In a recent government press conference held to launch the Visit Malaysia 2026 campaign, a question about national language ...

HUTCHMED unveils its innovative ATTC platform, potentially providing precision oncology with synergistic dual-mechanism of action — — Lead candidate HMPL-A251 harnesses a selective PI3K/PIKK inhibitor ...

Idience, a subsidiary specializing in the development of anticancer drugs, will present its oncology pipeline, including the ...

October 2025 proved to be a significant month for the oncology landscape, marked by a wave of key regulatory decisions from the US FDA. This period saw important full and accelerated drug approvals ...

The actor is stepping back into the spotlight once again with his role in Rachel Sennott ‘s HBO series I Love LA, which ...

An update from HUTCHMED (China) ( ($HK:0013) ) is now available. HUTCHMED (China) Limited announced significant advancements in its research and ...